rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2003-9-23
|
pubmed:abstractText |
Nitrates are widely used to treat coronary artery disease, but their therapeutic value is compromised by the rapid development of tolerance. Recently, the renin-angiotensin system has been suggested to play an important role in the development of nitrate tolerance.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Nitrates,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroglycerin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Thioredoxins,
http://linkedlifedata.com/resource/pubmed/chemical/candesartan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1524-4539
|
pubmed:author |
pubmed-author:HiraiNobutakaN,
pubmed-author:KajiwaraIchiroI,
pubmed-author:KawanoHiroakiH,
pubmed-author:MiyamotoShinzoS,
pubmed-author:NakamuraHajimeH,
pubmed-author:OgawaHisaoH,
pubmed-author:SakamotoTomohiroT,
pubmed-author:ShimomuraHidekiH,
pubmed-author:SoejimaHirofumiH,
pubmed-author:YasueHirofumiH,
pubmed-author:YodoiJunjiJ,
pubmed-author:YoshimuraMichihiroM
|
pubmed:issnType |
Electronic
|
pubmed:day |
23
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1446-50
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12952843-Administration, Cutaneous,
pubmed-meshheading:12952843-Aged,
pubmed-meshheading:12952843-Angina Pectoris,
pubmed-meshheading:12952843-Angiotensin Receptor Antagonists,
pubmed-meshheading:12952843-Benzimidazoles,
pubmed-meshheading:12952843-Biological Markers,
pubmed-meshheading:12952843-Brachial Artery,
pubmed-meshheading:12952843-Coronary Vasospasm,
pubmed-meshheading:12952843-Dose-Response Relationship, Drug,
pubmed-meshheading:12952843-Drug Tolerance,
pubmed-meshheading:12952843-Female,
pubmed-meshheading:12952843-Headache,
pubmed-meshheading:12952843-Hemodynamics,
pubmed-meshheading:12952843-Humans,
pubmed-meshheading:12952843-Male,
pubmed-meshheading:12952843-Middle Aged,
pubmed-meshheading:12952843-Nitrates,
pubmed-meshheading:12952843-Nitroglycerin,
pubmed-meshheading:12952843-Oxidative Stress,
pubmed-meshheading:12952843-Receptor, Angiotensin, Type 1,
pubmed-meshheading:12952843-Tetrazoles,
pubmed-meshheading:12952843-Thioredoxins,
pubmed-meshheading:12952843-Treatment Outcome,
pubmed-meshheading:12952843-Vascular Patency
|
pubmed:year |
2003
|
pubmed:articleTitle |
Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina.
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto City 860-8556, Japan. nobutaka@krmc.or.jp
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|